Search results for "Hypersensitivity"

showing 10 items of 364 documents

Correlación, en pacientes infectados por el VIH-1 y previamente tratados, entre la reacción de hipersensibilidad a abacavir y el alelo HLA-B*5701

2009

Introduction: Hypersensitivity reaction to abacavir (a powerful inverse transcriptase inhibitor) is a serious adverse effect that limits its use in antiretroviral treatment and requires a high level of clinical surveillance. Certain haplotypes of the primary histocompatibility complex proteins (HLA-B*5701) are very signifi cant predictors of the risk of hypersensitivity to this drug. The purpose of this study is to identify the cases where a probable hypersensitivity reaction to abacavir presented the HLA-B*5701 allele. Method: A retrospective study was conducted in all HIV-1 positive adult patients infected treated with abacavir between January 2000 and December 2007, in Department 6 of th…

PharmacologyDrugmedicine.medical_specialtyAdult patientsbusiness.industrymedia_common.quotation_subjectRetrospective cohort studyGastroenterologyRashSurgeryHypersensitivity reactionAbacavirInternal medicineAntiretroviral treatmentMedicinemedicine.symptombusinessAdverse effectmedia_commonmedicine.drugFarmacia Hospitalaria
researchProduct

Delayed-type skin reactions in bursectomized or thymectomized chickens.

1977

Chickens can easily be induced to develop delayed-type skin reactions to oxazolone when animals are sensitized 7 days before the challenge. The reaction is quantitated by assessing the increase in wattle thickness: maximum reactions occur 24 h after challenge. The reaction is inhibited by neonatal thymectomy or bursectomy; these findings therefore suggest also an important B-derived component in delayed hypersensitivity to oxazolone.

PharmacologyMaleChemistrymedicine.medical_treatmentOxazoloneCell BiologyThymus GlandDermatitis ContactWattle (anatomy)BursectomyOxazoloneDrug HypersensitivityCellular and Molecular NeuroscienceSkin reactionchemistry.chemical_compoundBursa of FabriciusDelayed hypersensitivityImmunologymedicineMolecular MedicineAnimalsHypersensitivity DelayedMolecular BiologyNeonatal thymectomyChickensExperientia
researchProduct

Demethylnobiletin inhibits delayed-type hypersensitivity reactions, human lymphocyte proliferation and cytokine production

2007

Background and purpose: Our aim was to examine the effect of demethylnobiletin on various experimental models of delayed-type hypersensitivity (DTH) reactions and to determine its influence on the mediators and enzymes involved in these reactions. Experimental approach: DTH was induced in mice by oxazolone, dinitrofluorobenzene (DNFB) and sheep red blood cells (SRBC). The effect of demethylnobiletin on the ensuing DTH was studied, especially in relation to oedema formation, cell infiltration and tissue damage. Its activity on different mediators implicated in DTH reactions was also determined and its effect on nitric oxide synthase (NOS)-2 analysed. Finally, its influence on T lymphocyte pr…

Pharmacologybiologymedicine.medical_treatmentLymphocyteLymphocyte proliferationPharmacologyNitric oxideOxazoloneNitric oxide synthasechemistry.chemical_compoundCytokinemedicine.anatomical_structurechemistryApoptosisDelayed hypersensitivityImmunologymedicinebiology.proteinBritish Journal of Pharmacology
researchProduct

Evaluation of the effectiveness of the photobiomodulation in the treatment of dentin hypersensitivity after basic therapy. A randomized clinical trial

2016

Background: Dentin hypersensitivity (DH) in one of the most common causes of patient discomfort in the general population and its prevalence is higher in patients who have received basic or surgical periodontal treatment. Efficiency of the diode laser with different wavelengths has been studied by several authors, showing an improvement rate of the DH between 60-98%. The aim of the present study was to evaluate the effect of photobiomodulation (PBM) treatment on the reduction of DH after non surgical periodontal treatment. Material and methods: A randomized split mouth clinical trial was performed involving 30 patients (120 teeth) diagnosed with DH after scaling and root planning. Two teeth…

PopulationDentistryOdontologialaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineThermal stimulationClinical trialsRandomized controlled triallawmedicineeducationGeneral DentistryGingival recessioneducation.field_of_studyLàsersDentin sensitivitybusiness.industryLasers030206 dentistrymedicine.diseaseLaser:CIENCIAS MÉDICAS [UNESCO]PhotobiologyClinical trialFotobiologiaImprovement rateDentistryUNESCO::CIENCIAS MÉDICASDentin hypersensitivitymedicine.symptombusinessHipersensibilitat dentinalAssaigs clínics
researchProduct

Systematic review of BRAF/MEK inhibitors‐induced Severe Cutaneous Adverse Reactions (SCARs)

2020

Severe cutaneous adverse reactions (SCARs) [Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and systemic syndrome (DRESS), acute generalized exanthematous pustulosis (AGEP), and generalized bullous fixed eruption (GBFE)] are severe drug reactions that often require hospitalization and could be fatal. BRAF and MEK inhibitors (BRAF/MEKi) are a standard of care in patients with BRAF-mutated metastatic melanomas. These agents are administered until disease progression or unacceptable toxicity occurs. This review has focus on BRAF/MEKi-induced SCARs. A systematic search of the following terms: 'vemurafenib', 'cobimetinib', 'dabrafenib', 'trametinib',…

Proto-Oncogene Proteins B-rafmedicine.medical_specialtyDermatologyCicatrix030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineHumansVemurafenibRetrospective StudiesMitogen-Activated Protein Kinase KinasesTrametinibCobimetinibbusiness.industryBinimetinibDabrafenibAcute generalized exanthematous pustulosismedicine.diseaseDermatologyToxic epidermal necrolysisInfectious DiseasesAcute Generalized Exanthematous PustulosischemistryDrug Hypersensitivity SyndromeStevens-Johnson Syndrome030220 oncology & carcinogenesisbusinessmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Pseudomonas corrugata contains a conserved N-acyl homoserine lactone quorum sensing system; its role in tomato pathogenicity and tobacco hypersensiti…

2007

Pseudomonas corrugata is a phytopathogenic bacterium, causal agent of tomato pith necrosis, yet it is an ubiquitous bacterium that is part of the microbial community in the soil and in the rhizosphere of different plant species. Although it is a very heterogeneous species, all the strains tested were able to produce short chain acyl homoserine lactone (AHL) quorum sensing signal molecules. The main AHL produced was N-hexanoyl-l-homoserine lactone (C6-AHL). An AHL quorum sensing system, designated PcoI/PcoR, was identified and characterized. The role of the quorum sensing system in the expression of a variety of traits was evaluated. Inactivation of pcoI abolished the production of AHLs. The…

Pseudomonas corrugateHypersensitivity responseVirulenceEcologyQuorum SensingSettore AGR/12 - Patologia VegetalePseudomonas corrugatatomato pith necrosisPseudomonaMicrobiologyApplied Microbiology and BiotechnologyPseudomonas corrugata; quorum sensing; tomato pith necrosisTomato pith necrosiSolanum lycopersicum4-ButyrolactonePseudomonasAcyl homoserine lactoneMutationTobaccoMicrobial antagonismLycopersicon esculentum
researchProduct

Hypersensitivity pneumonitis : Lessons from a randomized controlled trial in children

2021

Introduction Hypersensitivity pneumonitis (HP) in children is a severe interstitial lung disease and potentially, a chronic condition, if not treated appropriately. No evidence-based guidelines are available; in particular, the role of systemic glucocorticoid therapy is unclear. Methods The aim of this randomized, double-blind, placebo-controlled, parallel-group, multi-center, phase II trial in pediatric HP was to assess the outcome of HP in children after 6 months of treatment and to compare 3 months of treatment with oral prednisolone or placebo. Results After 1.5 years and the inclusion of only four children, we terminated the study prematurely. Two of the children randomized to predniso…

Pulmonary and Respiratory MedicineAdultChronic conditionPediatricsmedicine.medical_specialtyPrednisoloneMedizinPlacebolaw.inventionFEV1/FVC ratioRandomized controlled trialDouble-Blind MethodlawMedicineHumansChildGlucocorticoidsbusiness.industryInterstitial lung diseasemedicine.diseaseClinical trialPediatrics Perinatology and Child HealthPrednisolonebusinessLung Diseases InterstitialHypersensitivity pneumonitismedicine.drugAlveolitis Extrinsic Allergic
researchProduct

Asthma exacerbations and socio-economic status in French adults with persistent asthma: A prospective cohort study.

2017

Adults disadvantaged by poor socio-economic status (SES) are more severely affected by asthma compared to those with better SES. We aimed to determine whether the frequency of asthma exacerbations (AEx), as well as aspects related to AEx management, differed based on SES in patients treated with daily treatments.This study, part of the prospective observational cohort ASTRO-LAB, included French adult patients with persistent asthma. Patients were considered as low SES if they benefited from publicly funded special health insurance and/or were perceived as low SES by their general practitioner. AEx was defined as at least one of the following: asthma-related oral corticosteroid course, medic…

Pulmonary and Respiratory MedicineAdultHypersensitivity ImmediateMalePediatricsmedicine.medical_specialtyAdolescentGeneral PracticeComorbiditySeverity of Illness IndexBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineImmunology and AllergyMedicineHumans030212 general & internal medicineSocial determinants of healthAnti-Asthmatic AgentsProspective StudiesProspective cohort studySocioeconomic statusAsthmaAsthma exacerbationsMedical Assistancebusiness.industrysocial sciencesmedicine.diseaseAsthma030228 respiratory systemSocioeconomic FactorsPediatrics Perinatology and Child HealthCohortpopulation characteristicsObservational studyFemaleFrancebusinessEmergency Service HospitalCohort studyThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Anti-muscarinic drugs as preventive treatment of exercise-induced bronchoconstriction (EIB) in children and adults.

2020

Regular physical activity is strongly recommended to prevent chronic respiratory diseases, including asthma. On the other hand, vigorous physical training may trigger airway symptoms and bronchoconstriction. The transient airway narrowing occurring because of exercise is named exercise-induced bronchoconstriction (EIB). Despite management according to guidelines, a significant proportion of patients experiences uncontrolled EIB, which thus represents a relevant unmet medical need. In particular, although prevention and treatment of EIB are effectively based on the use of beta-2 bronchodilator drugs, high heterogeneity in individual responses has been reported. Furthermore, even though beta-…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentmedicine.drug_classBronchoconstrictionMuscarinic Antagonists03 medical and health sciencesYoung Adult0302 clinical medicineBronchodilatorAdministration InhalationRespiratory HypersensitivityMedicineAdrenergic DrugsHumans030212 general & internal medicineIntensive care medicineAdverse effectChildAsthmabusiness.industrymedicine.diseaseResponse VariabilityExercise-induced bronchoconstrictionBronchodilator AgentsAnti-muscarinic030228 respiratory systemDelayed-Action PreparationsSettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREAnti muscarinicSystematic reviewBronchoconstrictionFemalemedicine.symptomAirwaybusinesshuman activitiesPhysical Conditioning HumanRespiratory medicine
researchProduct

Smoking and Obesity Increase Airway Hyperesponsiveness Risk In the Elderly

2015

Objective of our study was assessing whether smoking and obesity might affect airways hyperresponsiveness (AHR) differently in younger and older subjects and whether this influence might be due to their different impacts on baseline lung function values at different ages. Methods 3,903 consecutive adult subjects with normal lung function (1,920 males; mean age 35.1±16.2; median FEV1:97.3% of predicted [interquartile range (IQR):89.7-105.2] and FEV1/FVC:84.6% of predicted [IQR:79.8-89.2]), having performed a methacholine test, were considered. They were subdivided into three groups according to age (18-39, 40-64 and ≥65 years) and into different sub-groups according to body mass index (BMI) …

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAgingAdolescentVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioBronchial Provocation Tests03 medical and health sciencesFEV1/FVC ratioYoung Adult0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineForced Expiratory VolumemedicineRespiratory HypersensitivityHumansObesityYoung adultMethacholine ChlorideAsthmaAgedRetrospective Studiesbusiness.industrySmoking030206 dentistryrespiratory systemMiddle Agedmedicine.diseaseObesityrespiratory tract diseases030228 respiratory systemPediatrics Perinatology and Child HealthPhysical therapyasthma agingMethacholineFemaleAirwaybusinessBody mass indexmedicine.drug
researchProduct